Neill Moray MacKenzie
Chief Executive Officer at Trimunocor Ltd.
Neill Moray MacKenzie active positions
Companies | Position | Start | End |
---|---|---|---|
Biotecnol-Serviços e Desenvolvimento SA
Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Director/Board Member | - | - |
Biotecnol Ltd.
Biotecnol Ltd. BiotechnologyHealth Technology Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom. | Director/Board Member | - | - |
Corporate Officer/Principal | - | - | |
Trimunocor Ltd.
Trimunocor Ltd. Miscellaneous Commercial ServicesCommercial Services Trimunocor Ltd. is a private company based in Harpenden, UK that focuses on developing ground-breaking solutions to protect premature neonates from chronic lung disease. Trimunocor is a spin-out based on IP from the Medical Research Council and University of Southampton. The British company's website provides information about their solution and their focus, as well as news and events. Visitors can also subscribe to stay up to date with the latest developments. The company was founded by Neill Moray MacKenzie and Howard Clark, with Neill Moray MacKenzie serving as CEO since incorporation. | Chief Executive Officer | - | - |
Founder | - | - |
Career history of Neill Moray MacKenzie
Former positions of Neill Moray MacKenzie
Companies | Position | Start | End |
---|---|---|---|
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Director/Board Member | 2002-11-30 | 2008-12-03 |
Corporate Officer/Principal | 2002-11-30 | 2008-12-03 |
Statistics
International
United Kingdom | 4 |
Portugal | 2 |
Operational
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectoral
Health Technology | 3 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Health Technology |
Biotecnol-Serviços e Desenvolvimento SA
Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal. | Commercial Services |
Biotecnol Ltd.
Biotecnol Ltd. BiotechnologyHealth Technology Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom. | Health Technology |
Trimunocor Ltd.
Trimunocor Ltd. Miscellaneous Commercial ServicesCommercial Services Trimunocor Ltd. is a private company based in Harpenden, UK that focuses on developing ground-breaking solutions to protect premature neonates from chronic lung disease. Trimunocor is a spin-out based on IP from the Medical Research Council and University of Southampton. The British company's website provides information about their solution and their focus, as well as news and events. Visitors can also subscribe to stay up to date with the latest developments. The company was founded by Neill Moray MacKenzie and Howard Clark, with Neill Moray MacKenzie serving as CEO since incorporation. | Commercial Services |